View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Comment
February 11, 2021

American Indians and Alaska Natives have worse Covid-19 outcomes than whites, reflects disparities in other health measures

By GlobalData Healthcare

The Centers for Disease Control and Prevention (CDC) in the US has reported that American Indians and Alaska Natives (AI / AN) are 3.5 times as likely to get Covid-19 as non-Hispanic whites and four times as likely to be hospitalised. Those who are sick also tend to have different characteristics and experience more severe symptoms than the general population. These findings are not surprising as AI / AN populations are a marginalised group in healthcare in the US. Covid-19 relief and vaccine roll-out should prioritise the AI / AN groups.

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

Understanding the impact of Covid-19 on the AI / AN community has many difficulties. Covid-19 hits those with underlying conditions such as diabetes, heart disease, and cancers harder. The AI / AN population has a higher risk of having these pre-existing conditions. The CDC reported that native Americans are twice as likely as whites to have diabetes, at 16% prevalence compared with 8% prevalence in non-Hispanic whites. A study published in the journal Cancer Epidemiology and Biomarkers Review by Melkonian and colleagues found that lung and colorectal cancer incidence are statistically significantly higher in the AI / AN population than whites. However, the health measure disparities known in AI / AN don’t entirely explain the unique characteristics of Covid-19 in the group, such as a higher-than-expected rate of infection in the younger population. This is partly because patient characteristics in Covid-19-positive AI / AN populations are largely missing. The CDC data showed that over 90% of Covid-19-positive AI / AN patients do not have information on underlying conditions. It is difficult to determine if the trends observed in the AI / AN population are due to higher rates of underlying conditions or other causes, which makes it difficult to develop effective public health measures to stop transmission.

Figure 1: US, Comparison of Incidence of Covid-19, Lung Cancer, and Colorectal Cancer Between American Indians, Alaska Natives and Non-Hispanic Whites.

Source: GlobalData; SEER Statistics Review 1975-2017; Melkonian et al., 2019; CDC                                                                                                                       © GlobalData

Note: Cancer incidence in non-Hispanic whites obtained from SEER; cancer incidence for American Indians, Alaska Natives obtained from Melkonian et al., 2019; both are rates adjusted to 2000 US standard population.

A successful roll-out of Covid-19 vaccines in the AI / AN population is going to be key to control the pandemic for this at-risk group. Public opinion regarding the acceptance of the vaccine within the tribal populations have been both positive and negative in the last year; however, news from this week shows an overwhelmingly positive attitude towards the vaccine currently. The Urban Indian Health Institute conducted a survey on Covid-19 vaccine perceptions and 75% of the respondents said they are willing to receive the vaccine. That is higher than the general US population, where 60% say they would definitely or probably get a vaccine, according to the Pew Research Center. The high level of acceptance of the vaccine could be due to partnerships involving the tribal populations early in the vaccine development phase. For example, the Johns Hopkins School of Public Health and the Center for American Indian Health teamed up to ensure there were opportunities for Native Americans to participate in the Pfizer Covid-19 vaccine clinical trials, in order to be able to study the safety and effectiveness of the vaccine in the population. GlobalData expects herd immunity to be reached when around 70% of the population either have recovered from the infection or have received vaccinations. If vaccine rollout can indeed reach 75% of the AI / AN population, it is hopeful the pandemic can be successfully controlled.

Related Companies

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena